Medicine » Critical Care and Emergency Medicine

Oncology Critical Care

Edited by Jeffrey B. Hoag, ISBN 978-953-51-2782-6, Print ISBN 978-953-51-2781-9, 184 pages, Publisher: InTech, Chapters published November 30, 2016 under CC BY 3.0 license
DOI: 10.5772/61590
Edited Volume

According to the American Cancer Society, more than 1.6 million people will be diagnosed with cancer during this year. Outcomes have steadily risen over the last several decades with the advent of newer therapies. As outcomes have improved, more and more cancer patients are developing critical illness. In the not-too-distant past, patients with active malignancy were thought not appropriate for critical care services as decreased longevity related to the cancer suggested poor prognosis for intensive care utilization. More recently, evidence supports rapid activation of critical care services leading to improved outcomes in cancer patients. Moreover, just as sub-subspecialty critical care experience in trauma and neurosciences has proved beneficial, the emerging field of oncology critical care warrants specific attention.

Dr. Jeffrey Hoag

CTCA

Dr. Jeffrey B. Hoag received his Doctor of Medicine degree from Virginia Commonwealth University School of Medicine in Richmond, Virginia, in 2001. After completing internship and residency in the same institution, he moved to Baltimore, Maryland, where he completed fellowship training at Johns Hopkins University in Pulmonary Medicine and Critical Care Medicine. Along with being an associate professor of Medicine at Drexel University College of Medicine, he is the director of Critical Care at the Eastern Regional Medical Center of Cancer Treatment Centers of America® in Philadelphia, Pennsylvania. Dr. Hoag is also the enterprise chief of Critical Care and vice chairman of Medicine for Medicine and Science, the clinical branch of Cancer Treatment Centers of America®.

Fields of Research

Experience

  • CTCA

Edited Books

  • Oncology Critical Care

    According to the American Cancer Society, more than 1.6 million people will be diagnosed with cancer during this year. Outcomes have steadily risen over the last several decades with the advent of newer therapies. As outcomes have improved, more and more cancer patients are developing critical illness. In the not-too-distant past, patients with active malignancy were thought not appropriate for critical care services as decreased longevity related to the cancer suggested poor prognosis for intensive care utilization. More recently, evidence supports rapid activation of critical care services leading to improved outcomes in cancer patients. Moreover, just as sub-subspecialty critical care experience in trauma and neurosciences has proved beneficial, the emerging field of oncology critical care warrants specific attention.